Sun Pharmaceutical gets USFDA approval for generic version of Plavix

18 May 2012 Evaluate

Sun Pharmaceutical Industries has received an approval from US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for its generic version of Plavix, Clopidogrel Tablets USP 75mg.

The generic Clopidogrel Tablets USP 75mg are therapeutic equivalent of Plavix tablets from Sanfoi-Aventis. Clopidogrel Tablets have annual sales of about $6.7 billion in the US.

Earlier in April, the company received an approval from USFDA for its abbreviated new drug application (ANDA) -- generic version of Zyprexa -- Olanzapine Tablets USP, 2.5mg, 5mg, 7.5mg, 10mg, 15mg and 20mg

Sun Pharmaceutical Industries manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.

Sun Pharma Inds. Share Price

1634.40 21.85 (1.35%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×